A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women

作者: Gavin J Blake , Nisha Dada , Jonathan C Fox , JoAnn E Manson , Paul M Ridker

DOI: 10.1016/S0735-1097(01)01554-6

关键词: Relative riskEndocrinologyProspective cohort studyCase-control studyLipoprotein-associated phospholipase A2Risk factorMedicineMyocardial infarctionC-reactive proteinUnivariate analysisInternal medicine

摘要: … correlation between Lp-… of Lp-PLA 2 may be limited to those with overt hyperlipidemia. Indeed, the strong correlation between Lp-PLA 2 and LDL likely explains why the distribution of Lp…

参考文章(21)
Shuichi Miyaura, Noriei Maki, William Byrd, John M. Johnston, The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma. Lipids. ,vol. 26, pp. 1015- 1020 ,(1991) , 10.1007/BF02536494
Shih-Jen Hwang, Christie M. Ballantyne, A. Richey Sharrett, Louis C. Smith, Clarence E. Davis, Antonio M. Gotto, Eric Boerwinkle, Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study Circulation. ,vol. 96, pp. 4219- 4225 ,(1997) , 10.1161/01.CIR.96.12.4219
Wolfgang Koenig, Malte Sund, Margit Fröhlich, Hans-Günther Fischer, Hannelore Löwel, Angela Döring, Winston L. Hutchinson, Mark B. Pepys, C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation. ,vol. 99, pp. 237- 242 ,(1999) , 10.1161/01.CIR.99.2.237
Paul M Ridker, Julie E Buring, Nader Rifai, None, Soluble P-Selectin and the Risk of Future Cardiovascular Events Circulation. ,vol. 103, pp. 491- 495 ,(2001) , 10.1161/01.CIR.103.4.491
Larry W. Tjoelker, Cheryl Wilder, Chris Eberhardt, Diana M. Stafforinit, Greg Dietsch, Brian Schimpf, Shawn Hooper, Hai Le Trong, Lawrence S. Cousens, Guy A. Zimmerman, Yoshiji Yamadat, Thomas M. Mclntyre, Stephen M. Prescott, Patrick W. Gray, Anti-inflammatory properties of a platelet-activating factor acetylhydrolase Nature. ,vol. 374, pp. 549- 553 ,(1995) , 10.1038/374549A0
Colin H. MACPHEE, Kitty E. MOORES, Helen F. BOYD, Dash DHANAK, Robert J. IFE, Colin A. LEACH, David S. LEAKE, Kevin J. MILLINER, Rebecca A. PATTERSON, Keith E. SUCKLING, David G. TEW, Deirdre M. B. HICKEY, Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochemical Journal. ,vol. 338, pp. 479- 487 ,(1999) , 10.1042/BJ3380479
Tamara B Harris, Luigi Ferrucci, Russell P Tracy, M.Chiara Corti, Sholom Wacholder, Walter H Ettinger, Harley Heimovitz, Harvey J Cohen, Robert Wallace, Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly∗∗Access the “Journal Club” discussion of this paper at http:/www.elsevier.com/locate/ajmselect/ The American Journal of Medicine. ,vol. 106, pp. 506- 512 ,(1999) , 10.1016/S0002-9343(99)00066-2
Paul M Ridker, Charles H Hennekens, Julie E Buring, Nader Rifai, None, C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women New England Journal of Medicine. ,vol. 342, pp. 836- 843 ,(2000) , 10.1056/NEJM200003233421202
Muriel J Caslake, Chris J Packard, Keith E Suckling, Stephen D Holmes, Paul Chamberlain, Colin H Macphee, Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease Atherosclerosis. ,vol. 150, pp. 413- 419 ,(2000) , 10.1016/S0021-9150(99)00406-2
Paul M Ridker, Nader Rifai, Meir J Stampfer, Charles H Hennekens, None, Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men Circulation. ,vol. 101, pp. 1767- 1772 ,(2000) , 10.1161/01.CIR.101.15.1767